Rostislav Vyzula

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

Ondřej Slabý, Marek Svoboda, Pavel Fabián et al. · Oncology · 2007 · 687 citations

Medicine, Molecular Biology, Oncology +16

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Martina Rédová, Alexandr Poprach, Jana Nekvindová et al. · Journal of Translational Medicine · 2012 · 278 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

René H.M. Verheijen, Leon F.A.G. Massuger, Benedict B. Benigno et al. · Journal of Clinical Oncology · 2006 · 191 citations · Full text

Medicine, Gynecology, Oncology +13

Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer

Petra Vychytilova‐Faltejskova, Lenka Radová, Milana Šachlová et al. · Carcinogenesis · 2016 · 164 citations · Full text

Medicine, Molecular Medicine, Oncology +17

MiR‐195, miR‐196b, miR‐181c, miR‐21 expression levels and <i>O</i>‐6‐methylguanine‐DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

Radek Lakomý, Jiří Šáňa, Simona Hankeová et al. · Cancer Science · 2011 · 156 citations · Full text

Medicine, Molecular Biology, Oncology +17